Navigation Links
Positive Phase 2 Results Reported with Boehringer Ingelheim's Investigational HCV Protease Inhibitor in Both Previously Treated and Untreated Patients
Date:4/1/2011

gated hyperbilirubinemia.  Average alanine aminotransferase (ALT) improved in all BI 201335 groups compared to placebo, and there was no excess anemia reported in the study.  Across BI 201335 treatment groups, 4 to 12 percent of patients discontinued BI 201335 due to AEs.  

(Oral abstract #66) SILEN-C2: Sustained Virologic Response and Safety of BI 201335 Combined with Peginterferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Patients with Non-Response to PegIFN/RBVThe SILEN-C2 study evaluated the virological response and safety of different doses of BI 201335 in treatment-experienced patients who did not respond to at least 12 weeks of prior treatment with PegIFN/RBV. This patient population is particularly difficult to treat, as patients who have not responded to PegIFN/RBV alone have low response rates to additional treatments. The trial did not include patients who relapsed after initial treatment with PegIFN/RBV.

In this double-blind, randomized, placebo-controlled trial, 288 treatment-experienced GT-1 HCV patients were randomized (2:1:1) to receive either:

  • BI 201335 240mg QD with a three-day LI of PegIFN/RBV;
  • BI 201335 240mg QD plus PegIFN/RBV without LI; or
  • BI 201335 240mg twice-daily (BID) with a three-day LI of PegIFN/RBV

  • In each group, patients were given BI 201335 for 24 weeks in combination with PegIFN/RBV, which was given for 24 or 48 weeks.

    Patients in the two BI 201335 QD groups who achieved eRVR were re-randomized to either stop all treatment at Week 24 or continue PegIFN/RBV until Week 48.

    Treatment Outcomes in SILEN-C2 (Treatment-Experienced Patients)240mg
    QD/LI
    (N=142)240mg
    QD
    (N=76)240mg
    BID/LI
    (N=70)eRVR, %

    43

    45

    47Overall SVR, %

    28

    41

    31Breakthrough*, %

    25

    28

    17Relapse**, %

    25

    9

    19*Rebound on treatment with BI 20133
    '/>"/>

    SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
    2. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
    3. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
    4. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
    5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    6. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
    7. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
    8. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
    9. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
    10. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
    11. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/27/2015)... N.Y. , May 27, 2015  VirtualScopics, ... of clinical trial imaging solutions, announced today, ahead ... Medicine (ISMRM) Annual Meeting in Toronto ... operational investments in Magnetic Resonance Elastography (MRE).  VirtualScopics, ... supporting pharmaceutical companies integrating MRE into their global, ...
    (Date:5/27/2015)... LONDON and NEW YORK ... - http://www.abmrg.com/Indonesia-Respiratory-Devices-and-Respiratory-Diagnostics-Market-through-2020---Detailed-analysis-of-Hospital-and-Retail-market.html - Over 70% Indonesian ... Around 400,000 Indonesians die annually due to smoking-related conditions; ... Three-fourths of 6.5 million vehicles in Jakarta ... Indonesia is the fourth ...
    (Date:5/27/2015)... N.J. , May 27, 2015  Cambrex Corporation (NYSE: ... , Executive Vice President and Chief Financial Officer, will present ... 2015 at 8:00 a.m. EDT in New York ... slide presentation can be accessed from the Cambrex website at ... Presentations", and a replay will be available for 90 days ...
    Breaking Medicine Technology:VirtualScopics, Inc. Makes Investments In Magnetic Resonance Elastography (MRE) 2VirtualScopics, Inc. Makes Investments In Magnetic Resonance Elastography (MRE) 3VirtualScopics, Inc. Makes Investments In Magnetic Resonance Elastography (MRE) 4Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 2Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 3Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 4
    ... Calif., Oct. 6 PRO-DEX, INC. (Nasdaq: PDEX ... as Chief Financial Officer, effective October 6, 2010.  Mr. Hurwitz ... "Hal comes to Pro-Dex with a broad financial background ... with Coopers & Lybrand LLP, now part of PricewaterhouseCoopers LLP, ...
    ... DiFUSION Technologies Inc., a medical device company focused ... CleanFUZE™ anti-microbial technology for orthopedic implants, announced today ... of posterior interbody devices indicated for intervertebral body ... SI, in skeletally mature patients who have had ...
    Cached Medicine Technology:Pro-Dex, Inc. Appoints Harold A. Hurwitz as Chief Financial Officer 2DiFUSION Technologies Receives 510(k) Clearance of Xiphos™ Interbody Implants for Spinal Fusion 2
    (Date:5/27/2015)... May 27, 2015 SAN DIEGO, ... Gulfport Mississippi, is the first healthcare provider along ... to chronic care management (CCM). In partnership with ... is introducing RevUp, a new program that enables ... and increase monthly reimbursements. This new, user-friendly program ...
    (Date:5/27/2015)... May 27, 2015 Coco Libre announced today ... able to reach for Organic Coconut Water to quench their ... be available at VIP areas, artist greenrooms, corporate skyboxes and ... at area hotels and on festival shuttle buses. , ... year,” said Noa Elan, Director of Strategic Partnerships for Latitude ...
    (Date:5/27/2015)... 27, 2015 This is a ... of the Omega-3 industry. The report provides a ... applications and industry chain structure. The Omega-3 market ... development trends, competitive landscape analysis, and key regions ... Camanchaca Fishing Company, Seadragon Marine Oils, Norwegian Fish ...
    (Date:5/27/2015)... With InnerVoice Communication App you will ... is not only heard but seen -- by a photograph ... image. This award-winning and affordable app takes full advantage of ... InnerVoice Sender app in conjunction with InnerVoice Communication ... remotely for no additional cost. , InnerVoice Sender ...
    (Date:5/27/2015)... For a limited time, San Fernando ... discounts on facial fillers. Skin loses more than 2 percent ... This lost collagen can lead to thinning or sagging skin, ... Facial fillers are an excellent way to plump skin and ... to create a softer and more youthful appearance, without the ...
    Breaking Medicine News(10 mins):Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 3Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Discounts on Facial Fillers 2
    ... , KUNMING, China, Nov. ... Equities: KUN) ("China Shenghuo" or,the "Company"), which is engaged ... supplement and cosmetic products,in the People,s Republic of China ... ended September 30, 2009. , , ...
    ... Targeting the normal cells that surround cancer cells within ... greatly increase the effectiveness of traditional anti-cancer treatments, say ... Journal of Clinical Investigation published online November 16, ... (FAP), expressed by one type of these so-called "stromal" ...
    ... Reston, Va. If cost-cutting U.S. Preventive Services ... policy, two decades of decline in breast cancer ... may die needlessly from breast cancer each year. ... committee with no medical imaging representation ─ would ...
    ... For those who,ve had an attack already, stressful games ... (HealthDay News) -- Reduced blood flow to the heart ... attack are at increased risk for another while watching ... included 38 male heart attack survivors who watched live ...
    ... , FORT LAUDERDALE, Fla., Nov. 16 ... Risk Management, Inc., announced today that it has been ... health care accrediting organization that establishes quality standards for ... require companies to establish a process to assess, plan ...
    ... , ATLANTA, Nov. 16 The nation,s premier public health ... signed a two-year contract with Georgia Power to purchase renewable ... http://www.newscom.com/cgi-bin/prnh/20050216/CLW066LOGO ) , The purchase ... percent of the organization,s annual kilowatt-hour consumption, will make the ...
    Cached Medicine News:Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 2Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 3Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 4Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 5Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 6Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 7Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 8Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 9Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 10Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 11Health News:Wistar researchers show targeting 'normal' cells in tumors slows growth 2Health News:Wistar researchers show targeting 'normal' cells in tumors slows growth 3Health News:USPSTF mammography recommendations will result in countless unnecessary breast cancer deaths each year 2Health News:USPSTF mammography recommendations will result in countless unnecessary breast cancer deaths each year 3Health News:Patriot Risk Services, Inc. Receives URAC Case Management Accreditation 2Health News:Georgia Power, Centers for Disease Control and Prevention Forge Green Energy Partnership 2
    ... portable NEVA™ System is designed ... changes within the penis nocturnally. ... to monitor and record impedance ... changes in penile blood volume. ...
    ... designed for vascular labs already equipped ... Its primary use will be for ... cuff with air. Blood pressures ... - a proximal occluding cuff connected ...
    ... your patients come to you with ... they can understand. Then they want ... Rigidity Assessment System can you gather, ... rigidity and tumescence data...and provide the ...
    ... The table top design takes into ... and creates a flexible working environment for ... the alphamaxx can be matched exactly to ... top slide capability creates superior access for ...
    Medicine Products: